KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio-Rad Laboratories (BIO) Other Non Operating Income (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Other Non Operating Income for 17 consecutive years, with -$60.5 million as the latest value for Q4 2025.

  • Quarterly Other Non Operating Income fell 4553.85% to -$60.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$48.9 million through Dec 2025, down 12125.0% year-over-year, with the annual reading at $1.2 million for FY2025, 25.0% down from the prior year.
  • Other Non Operating Income for Q4 2025 was -$60.5 million at Bio-Rad Laboratories, down from $8.3 million in the prior quarter.
  • The five-year high for Other Non Operating Income was $17.4 million in Q1 2021, with the low at -$60.5 million in Q4 2025.
  • Average Other Non Operating Income over 5 years is -$2.8 million, with a median of $800000.0 recorded in 2023.
  • The sharpest move saw Other Non Operating Income surged 1661.0% in 2021, then plummeted 4553.85% in 2025.
  • Over 5 years, Other Non Operating Income stood at $10.8 million in 2021, then plummeted by 490.45% to -$42.2 million in 2022, then skyrocketed by 93.17% to -$2.9 million in 2023, then soared by 54.86% to -$1.3 million in 2024, then tumbled by 4553.85% to -$60.5 million in 2025.
  • According to Business Quant data, Other Non Operating Income over the past three periods came in at -$60.5 million, $8.3 million, and $600000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.